Doctors Warn Against Viral ‘Glowing Skin’ IV Drips as Safety Concerns Grow

The promise of “glass skin” in a drip has helped make intravenous beauty treatments increasingly popular, but doctors are warning consumers to think twice before getting an IV infusion purely for cosmetic reasons.

Among the most widely promoted treatments are glutathione IV drips, often advertised as a way to brighten the complexion, reduce pigmentation or achieve a more youthful “glow”. However, dermatology experts say the evidence supporting routine IV glutathione for cosmetic purposes is weak, while the risks associated with intravenous treatment should not be underestimated.

What is the viral glowing-skin IV drip?

Many beauty and wellness clinics market IV “glow” treatments containing ingredients such as glutathione, vitamin C, collagen-related products and other compounds.

Glutathione is a naturally occurring antioxidant, but its intravenous use for skin lightening is an off-label cosmetic practice rather than a well-established treatment for achieving permanently lighter skin.

A recent position statement from the Association of Cutaneous Surgeons of India Task Force said there is insufficient evidence to recommend IV glutathione routinely for aesthetic practice. It also noted that any skin-lightening effect reported in studies can be temporary.

The risks go beyond a needle prick

IV treatment carries risks that don't come with ordinary topical skincare.

According to the Indian dermatology task force, IV aesthetic treatments can result in infections, allergic reactions, bruising, fluid overload and electrolyte disturbances. Poor sterile technique can also lead to serious infections, including sepsis. Severe allergic reactions can progress to anaphylaxis.

There are also concerns specific to glutathione injections. Previous regulatory reviews have identified reported complications including kidney dysfunction, thyroid problems, severe abdominal pain and serious skin reactions such as Stevens-Johnson syndrome and toxic epidermal necrolysis.

Fresh FDA warning puts spotlight on injectable glutathione

The concerns have gained fresh attention after the US Food and Drug Administration (FDA) issued a warning on August 27, 2026, about the use of dietary-supplement-grade glutathione in injectable preparations.

The FDA said it was aware of at least 30 patients who experienced adverse events after receiving IV glutathione, either alone or alongside other ingredients. Reported symptoms included fever, chills, pain, dizziness and signs of shock or sepsis-like illness, with some patients requiring hospitalisation.

The agency said some compounded glutathione products were found to have concerns involving excessive bacterial endotoxins. Such contamination can cause severe inflammatory reactions and, in extreme cases, shock and death.

India has also raised concerns over injectable cosmetics

The issue is particularly relevant in India, where beauty clinics and wellness centres have increasingly marketed injectable treatments.

In May 2026, India's drug regulator CDSCO clarified that cosmetics cannot simply be injected into the human body as cosmetic products. The regulatory scrutiny has brought glutathione drips and other so-called wellness injections under greater attention.

Reports have described a wider market for injectable products promising skin enhancement, anti-ageing effects, energy boosts and other benefits, sometimes outside conventional medical settings.

Does the drip actually give you permanent glowing skin?

That is another major question.

The available evidence does not establish IV glutathione as a reliable, long-term skin-lightening treatment. The Indian dermatology task force said studies have shown limited and temporary effects, with skin colour potentially returning toward its original state after treatment stops. It also noted the lack of adequate studies assessing the long-term safety of IV glutathione.

In other words, consumers may be accepting an invasive treatment with potentially serious complications for a cosmetic result that is uncertain and may not last.

Doctors' message: don't treat a beauty trend like a harmless facial

The popularity of IV “glow” treatments has been fuelled by social media, celebrity culture and before-and-after marketing. But experts stress that an IV infusion is a medical procedure, not simply another salon beauty treatment.

Anyone considering such treatment should discuss the ingredients, indication, source and potential risks with a qualified medical professional. Treatments involving injections should be performed in an appropriate clinical setting with proper sterile precautions and emergency facilities.

The bottom line is simple: a glowing-skin promise does not make an IV drip risk-free. With regulators now flagging quality-control problems and dermatologists questioning the evidence for cosmetic IV glutathione, consumers should be especially cautious about treatments marketed as quick fixes for skin appearance.